glp-1 is it safe Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity New study confirms GLP-1 medications

it exists in several different forms, known as "vitamers," depending on the specific molecule attached to that central cobalt atom

The common side effects reported with GLP-1 weight-loss injections such as Ozempic include: nausea vomiting persistent stomach discomfort constipation diarrhoea bloating reflux-like symptoms fatigue dizziness reduced desire to eat to the point of food aversion For many people, eating becomes uncomfortable rather than supportive

Without validated biomarkers of efficacy, real-world results remain anecdotal at best

372:1 Shabil M, Bushi G, Beig MA, Rais MA, Ahmed M, Padhi BK (2023) Cardiovascular manifestation in tuberculosis cases: a systematic review and meta-analysis

A Mayo Clinic study found postmenopausal women using hormone therapy alongside tirzepatide (a GLP-1/GIP dual agonist) experienced notably greater weight loss compared with those using tirzepatide without HRT

Hannah Legg is 5'8" tall, and currently weighs 175 pounds